Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: Mol Cancer Res. 2018 Jun 14;16(10):1523–1529. doi: 10.1158/1541-7786.MCR-18-0281

Figure 3: Daxx heterozygosity contributes to carcinoma development in cooperation with low dose ionizing radiation.

Figure 3:

A) Schematic representation of experimental procedure. Mice were treated with four weekly doses of ionizing radiation (IR, 4 × 0.7 Gy), starting at 4 weeks of age. Mice were monitored until moribund, or until the 2-year experimental endpoint. B) Survival analysis. C) Tumor spectrum of mice from both genotypes. Chi-squared analysis of the proportions of different tumor types in DaxxΔ3/+ compared to those expected from wild-type controls, *p<0.013. Tumors that were present when mice were moribund or autopsied are included in this analysis. D) Representative H&E sections of identified ovarian pathology from both genotypes. Cysts were identified only in DaxxΔ3/+ mice, and carcinomas in both genotypes. Cyst is at 10x and carcinomas at 40x magnification. E) Representative H&E sections of papillary carcinomas observed in DaxxΔ3/+ mice. Images are at 20x magnification. F) Immunoblot analysis of four DaxxΔ3/+ tumors. HCC, hepatocellular carcinoma; Vcl, vinculin. G) H&E sections of islet pathology identified in DaxxΔ3/+ mice. Images are at 10x magnification.